✦ LIBER ✦

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

✍ Scribed by Gervais, Radj; Robinet, Gilles; Clément-Duchêne, Christelle; Denis, Fabrice; Kouri, Claude El; Martin, Philippe; Chouaki, Nadia; Bourayou, Nawel; Morère, Jean-François

Book ID: 123321518
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 303 KB
Volume: 80
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of carboplatin and pacl

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Preoperative treatment with paclitaxel a

Preoperative treatment with paclitaxel and carboplatin in locally advanced non small cell lung cancer (NSCLC): A phase II trial

✍ De Candis, D; Stani, S.C; Bidoli, P; Potepan, P; Bedini, V.A; Cataldo, I; Michet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A Phase II Trial of First-line Bevacizum

A Phase II Trial of First-line Bevacizumab in Combination With Pemetrexed and Carboplatin in Advanced Nonsquamous Non–Small-Cell Lung Cancer: Preliminary Results

✍ Z. Skaff; A. Hageboutros; K. Krieger; S. Coakley; R. Somer; J. Stevenson 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 43 KB

A phase I/II trial of carboplatin and na

A phase I/II trial of carboplatin and navelbine® in advanced non small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

191 Phase II trial of paclitaxel and car

191 Phase II trial of paclitaxel and carboplatin as first line treatment in advanced non small cell lung-cancer (NSCLS)

✍ Schütte, W.; Bork, I.; Schädlich, St.; Meyer, M.; Blankenburg, Th. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 166 KB

227 Paclitaxel, carboplatin and mitomyci

227 Paclitaxel, carboplatin and mitomycin as first-line treatment in patients (PTS) with advanced non-small cell lung cancer (NSCLC)

✍ Zarogoulidis, K.; Papagiannis, A.; Constantinidis, T.C.; Vogiatzis, A.K.; Pella, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB